WAIDDEN PHARMA focuses its main efforts on the search and development of effective solutions in Women’s Health.

WAIDDEN PHARMA, has launched recently a Contraceptive whose combination is the AEMPS and the EMEA´s first recommendation.

WAIDDEN PHARMA commercializes ALOGESIA®, an Ibuprofen Lysine of 600 mg, for mild-moderate pain, which acts in just 7 minutes, which makes it suitable for PMS, menstrual pain, …, and other discomfort for women.


WAIDDEN PHARMA has a relevant focus on Urology. Important products, owns and licenses, will be marketed shortly to reinforce its presence in this area.